Results 81 to 90 of about 153,171 (297)

Functional and Structural Evidence of Neurofluid Circuit Aberrations in Huntington Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Disrupted neurofluid regulation may contribute to neurodegeneration in Huntington disease (HD). Because neurofluid pathways influence waste clearance, inflammation, and the distribution of central nervous system (CNS)–delivered therapeutics, understanding their dysfunction is increasingly important as targeted treatments emerge.
Kilian Hett, Abigail Dubois, Melanie Leguizamon, Alexander Song, Paula Trujillo, Colin D. McKnight, Ciaran M. Considine, Manus J. Donahue, Daniel O. Claassen   +8 more
wiley   +1 more source

Monomorphic post-transplant lymphoproliferative disorder of the tongue: case report and review of literature

Diagnostic Pathology, 2007
Background Post-transplant lymphoproliferative disorder (PTLD) is a spectrum of hematological diseases arising in context of immunosuppression after organ transplantation. PTLD can involve any organ; however, it is extremely rare in oral cavity.
Zimrin Ann, Gocke Christopher D, Burke Allen P, Tavora Fabio, Gonzalez-Cuyar Luis F, Sauk John J, Zhao Xiafeng F   +6 more
doaj   +1 more source

Influenza Vaccination Responses in Disabled Stroke Patients: A Single‐Center Prospective Observational Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to investigate the immunological response to influenza vaccination, the incidence and severity of influenza infection, and the side effects of the vaccination in patients with ischemic stroke. Methods This prospective observational study was conducted between 2023 and 2024 at Ramathibodi Hospital.
Achiraya Pakngao, Sureerat Suwatcharangoon, Pintip Ngamjanyapron, Kobporn Boonnak, Thanitta Suangtamai, Porpon Rotjanapan   +5 more
wiley   +1 more source

A transplant recipient with a mixed germ-cell ovarian tumor

Saudi Journal of Kidney Diseases and Transplantation, 2008
Immunosuppressed renal transplant recipients seem to be at significantly increased risk of developing neoplasms comparatively to nonimmunosuppressed individuals. A history of malignancy exposes the patient to a high risk for relapse after transplantation.
Ketata Hafed, Bouacida Mahdi, Bouhlel Abdelkader, Sahnoun Ahmed, Bahloul Ali, Yaich Soumaya, Hachicha Jamil, Mhiri Mohamed   +7 more
doaj  

Rare myeloid sarcoma/acute myeloid leukemia with adrenal mass after allogeneic mobilization peripheral blood stem cell transplantation

Cancer Biology & Medicine, 2013
Myeloid sarcoma (MS) is a rare hematological neoplasm that develops either de novo or concurrently with acute myeloid leukemia (AML). This neoplasm can also be an initial manifestation of relapse in a previously treated AML that is in remission.
Ya-Fei Wang, Qian Li, Wen-Gui Xu, Jian-Yu Xiao, Qing-Song Pang, Qing Yang, Yi-Zuo Zhang   +6 more
doaj   +1 more source

The fate of intra-ductal papillary mucinous neoplasm of the pancreas after liver transplantation

, 2014
Background: Due to the burden of immunosuppression, presence of pre-malignant disease may be relative contraindication to liver transplantation (LT). We report a single-center experience of patients with intra-ductal papillary mucinous neoplasms (IPMN ...
Carrai P, Bartolozzi C, Campani D, Silvestri A, De Simone P, Catalano G, Ghinolfi D, Filipponi F., Coletti L, Tincani G   +9 more
core   +1 more source

Venetoclax monotherapy as front-line therapy for blastic plasmacytoid dendritic cell neoplasm

, 2023
Venetoclax is an approved treatment for relapsed/refractory Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). We report a unique case of venetoclax monotherapy used for front-line induction and as a bridge to allogeneic hematopoietic stem cell ...
Ankit Mitesh Shah, Poveda, Julio, Shah, Ankit Mitesh, Pereira, Denise, Julio Poveda, Wang, Trent Peng, Denise Pereira, Trent Peng Wang   +7 more
core   +1 more source

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi, Mohammed Dibas, Patricia Tai, Ala Dibas, Osama Souied, Suhair Al‐Ghabeesh   +5 more
wiley   +1 more source

Case Report Allogeneic Hematopoietic Cell Transplantation for Therapy-Related Myeloid Leukemia following Orthotopic Cardiac Transplantation

, 2020
Therapy-related myeloid neoplasm (t-MN) is a subtype of acute myeloid leukemia with adverse cytogenetics and poor overall prognosis despite intensive induction chemotherapy and allogeneic hematopoietic cell transplantation (allo-HCT).
Richard A Larson, K Kawauchi, D J Allsup, Koen Van Besien, K Khair, Elizabeth S Rich, P Tsirigotis, E Bissé, Richard J Lin   +8 more
core  

Marked Long‐Term Improvement in Lung Function in Melanoma Differentiation–Associated Protein 5 Antibody–Positive Dermatomyositis Patients: Experience of a Single‐Center Longitudinal Cohort in North America

Arthritis Care &Research, EarlyView.
Objective The objective of this study was to describe the longitudinal disease course and pulmonary outcomes of North American patients with melanoma differentiation–associated protein 5 (MDA5) antibody–associated dermatomyositis (DM). Methods Thirty patients with MDA5 antibody–associated DM were identified in a single‐center longitudinal cohort of 352
Jenice X. Cheah, Sangmee S. Bae, Tiffany De Leon, Yuna Lee, Rong Guo, David Elashoff, Jennifer Wang, Ani Shahbazian, Christina Charles‐Schoeman   +8 more
wiley   +1 more source